US8824752B1 - Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics - Google Patents

Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics Download PDF

Info

Publication number
US8824752B1
US8824752B1 US14/163,589 US201414163589A US8824752B1 US 8824752 B1 US8824752 B1 US 8824752B1 US 201414163589 A US201414163589 A US 201414163589A US 8824752 B1 US8824752 B1 US 8824752B1
Authority
US
United States
Prior art keywords
patient
image
anatomy
anatomic
computer system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US14/163,589
Other languages
English (en)
Other versions
US20140275945A1 (en
Inventor
Timothy A. Fonte
Leo J. Grady
Zhongle Wu
Michiel Schaap
Stanley C. Hunley
Souma Sengupta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HeartFlow Inc
Original Assignee
HeartFlow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HeartFlow Inc filed Critical HeartFlow Inc
Priority to US14/163,589 priority Critical patent/US8824752B1/en
Priority to US14/172,594 priority patent/US8831315B1/en
Priority to US14/172,554 priority patent/US8861820B2/en
Priority to US14/172,536 priority patent/US8831314B1/en
Priority to JP2016500462A priority patent/JP6255473B2/ja
Priority to DE202014010690.8U priority patent/DE202014010690U1/de
Priority to EP14713284.9A priority patent/EP2803038B1/en
Priority to KR1020207030780A priority patent/KR102312011B1/ko
Priority to CN201480015889.9A priority patent/CN105051784B/zh
Priority to DE202014010689.4U priority patent/DE202014010689U1/de
Priority to PCT/US2014/019008 priority patent/WO2014149496A1/en
Priority to CA2904832A priority patent/CA2904832C/en
Priority to EP20151462.7A priority patent/EP3664026B1/en
Priority to KR1020157026093A priority patent/KR102172182B1/ko
Priority to AU2014238124A priority patent/AU2014238124A1/en
Assigned to HEARTFLOW, INC. reassignment HEARTFLOW, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WU, ZHONGLE, FONTE, TIMOTHY A., GRADY, LEO J., HUNLEY, STANLEY C., SCHAAP, MICHIEL, SENGUPTA, SOUMA
Publication of US8824752B1 publication Critical patent/US8824752B1/en
Application granted granted Critical
Priority to US14/484,112 priority patent/US9008405B2/en
Publication of US20140275945A1 publication Critical patent/US20140275945A1/en
Priority to US14/554,653 priority patent/US9672615B2/en
Priority to US15/185,668 priority patent/US9836840B2/en
Priority to AU2016222402A priority patent/AU2016222402B2/en
Priority to JP2017134438A priority patent/JP6410891B2/ja
Priority to US15/802,840 priority patent/US10719931B2/en
Priority to JP2018178762A priority patent/JP6656331B2/ja
Priority to JP2020016765A priority patent/JP2020080165A/ja
Priority to US16/902,721 priority patent/US11494904B2/en
Assigned to HAYFIN SERVICES LLP reassignment HAYFIN SERVICES LLP SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEARTFLOW, INC.
Priority to US17/739,558 priority patent/US11803965B2/en
Priority to US18/472,729 priority patent/US20240013388A1/en
Assigned to HAYFIN SERVICES LLP reassignment HAYFIN SERVICES LLP SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEARTFLOW, INC.
Assigned to HEARTFLOW, INC. reassignment HEARTFLOW, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: HAYFIN SERVICES LLP
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/032—Transmission computed tomography [CT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0883—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the heart
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2576/00—Medical imaging apparatus involving image processing or analysis
    • A61B2576/02—Medical imaging apparatus involving image processing or analysis specially adapted for a particular organ or body part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0263—Measuring blood flow using NMR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/507—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for determination of haemodynamic parameters, e.g. perfusion CT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5258—Devices using data or image processing specially adapted for radiation diagnosis involving detection or reduction of artifacts or noise
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5294—Devices using data or image processing specially adapted for radiation diagnosis involving using additional data, e.g. patient information, image labeling, acquisition parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/52—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/5215—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data
    • A61B8/5223—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data for extracting a diagnostic or physiological parameter from medical diagnostic data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
    • G01R33/5635—Angiography, e.g. contrast-enhanced angiography [CE-MRA] or time-of-flight angiography [TOF-MRA]
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10072—Tomographic images
    • G06T2207/10081—Computed x-ray tomography [CT]
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10072—Tomographic images
    • G06T2207/10088—Magnetic resonance imaging [MRI]
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10072—Tomographic images
    • G06T2207/10104—Positron emission tomography [PET]
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10072—Tomographic images
    • G06T2207/10108—Single photon emission computed tomography [SPECT]
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10132—Ultrasound image
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30101—Blood vessel; Artery; Vein; Vascular
    • G06T2207/30104—Vascular flow; Blood flow; Perfusion
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30168—Image quality inspection
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30172—Centreline of tubular or elongated structure
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30196—Human being; Person
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2210/00—Indexing scheme for image generation or computer graphics
    • G06T2210/41—Medical
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Definitions

  • Embodiments of the present disclosure relate to methods and systems for assessing medical image quality and, more particularly, to methods and systems for assessing medical image quality in relation to patient-specific modeling of anatomy and/or blood flow.
  • Medical imaging is an important technology used to gain anatomic and physiologic data about a patient's body, organs, tissues, or a portion thereof for clinical diagnosis and treatment planning.
  • Medical imaging includes, but is not limited to, radiography, computed tomography (CT), magnetic resonance imaging (MRI), fluoroscopy, single-photon emission computed tomography (SPECT), positron emission tomography (PET), scintigraphy, ultrasound, and specific techniques such as echocardiography, mammography, intravascular ultrasound, and angiography. Imaging data may be obtained through non-invasive or invasive procedures.
  • CT computed tomography
  • MRI magnetic resonance imaging
  • SPECT single-photon emission computed tomography
  • PET positron emission tomography
  • scintigraphy ultrasound
  • specific techniques such as echocardiography, mammography, intravascular ultrasound, and angiography.
  • Imaging data may be obtained through non-invasive or invasive procedures.
  • the fields of cardiology, neuroscience, oncology, orthopedics, and many others benefit
  • coronary artery disease may cause the blood vessels providing blood to the heart to develop lesions, such as a stenosis (abnormal narrowing of a blood vessel). As a result, blood flow to the heart may be restricted.
  • a patient suffering from coronary artery disease may experience chest pain, referred to as chronic stable angina during physical exertion or unstable angina when the patient is at rest.
  • a more severe manifestation of disease may lead to myocardial infarction, or heart attack.
  • Patients suffering from chest pain and/or exhibiting symptoms of coronary artery disease may be subjected to one or more tests, such as based on medical imaging, that may provide some indirect evidence relating to coronary lesions.
  • noninvasive coronary evaluation may include electrocardiograms, biomarker evaluation from blood tests, treadmill tests, and echocardiography. These noninvasive tests, however, typically do not provide a direct assessment of coronary lesions or assess blood flow rates.
  • the noninvasive tests may provide indirect evidence of coronary lesions by looking for changes in electrical activity of the heart (e.g., using electrocardiography (ECG)), motion of the myocardium (e.g., using stress echocardiography), perfusion of the myocardium (e.g., using PET or SPECT), or metabolic changes (e.g., using biomarkers).
  • ECG electrocardiography
  • motion of the myocardium e.g., using stress echocardiography
  • perfusion of the myocardium e.g., using PET or SPECT
  • metabolic changes e.g., using biomarkers
  • anatomic data may be obtained noninvasively using coronary computed tomographic angiography (CCTA).
  • CCTA may be used for imaging of patients with chest pain and involves using CT technology to image the heart and the coronary arteries following an intravenous infusion of a contrast agent.
  • CT technology to image the heart and the coronary arteries following an intravenous infusion of a contrast agent.
  • CCTA also cannot provide direct information on the functional significance of coronary lesions, e.g., whether the lesions affect blood flow.
  • CCTA is purely a diagnostic test, it can neither be used to predict changes in coronary blood flow, pressure, or myocardial perfusion under other physiologic states (e.g., exercise), nor can it be used to predict outcomes of interventions.
  • Diagnostic cardiac catheterization may include performing conventional coronary angiography (CCA) to gather anatomic data on coronary lesions by providing a doctor with an image of the size and shape of the arteries.
  • CCA coronary angiography
  • CCA does not provide data for assessing the functional significance of coronary lesions.
  • a doctor may not be able to diagnose whether a coronary lesion is harmful without determining whether the lesion is functionally significant.
  • CCA has led to a procedure referred to as an “oculostenotic reflex,” in which interventional cardiologists insert a stent for every lesion found with CCA regardless of whether the lesion is functionally significant.
  • CCA may lead to unnecessary operations on the patient, which may pose added risks to patients and may result in unnecessary health care costs for patients.
  • the functional significance of a coronary lesion may be assessed invasively by measuring the fractional flow reserve (FFR) of an observed lesion.
  • FFR is defined as the ratio of the mean blood pressure downstream of a lesion divided by the mean blood pressure upstream from the lesion, e.g., the aortic pressure, under conditions of increased coronary blood flow, e.g., when induced by intravenous administration of adenosine.
  • Blood pressures may be measured by inserting a pressure wire into the patient.
  • HeartFlow, Inc. has developed simulation and modeling technology based on patient-specific imaging data.
  • various simulation, modeling, and computational techniques include, but are not limited to: computational mechanics, computational fluid dynamics (CFD), numerical simulation, multi-scale modeling, monte carlo simulation, machine learning, artificial intelligence and various other computational methods to solve mathematical models.
  • CFD computational fluid dynamics
  • These techniques may provide information about biomechanics, fluid mechanics, changes to anatomy and physiology over time, electrophysiology, stresses and strains on tissue, organ function, and neurologic function, among others. This information may be provided at the time of the imaging study or prediction of changes over time as a result of medical procedures or the passage of time and progression of disease.
  • HeartFlow, Inc. for modeling vascular blood flow from non-invasive imaging data, including assessing the effect of various medical, interventional, or surgical treatments (see, e.g., U.S. Pat. Nos. 8,386,188; 8,321,150; 8,315,814; 8,315,813; 8,315,812; 8,311,750; 8,311,748; 8,311,747; and 8,157,742).
  • HeartFlow, Inc. has developed methods for assessing coronary anatomy, myocardial perfusion, and coronary artery flow, noninvasively, to reduce the above disadvantages of invasive FFR measurements.
  • CFD simulations have been successfully used to predict spatial and temporal variations of flow rate and pressure of blood in arteries, including FFR.
  • Such methods and systems benefit cardiologists who diagnose and plan treatments for patients with suspected coronary artery disease, and predict coronary artery flow and myocardial perfusion under conditions that cannot be directly measured, e.g., exercise, and to predict outcomes of medical, interventional, and surgical treatments on coronary artery blood flow and myocardial perfusion.
  • the characteristics and quality of the image data is important.
  • a variety of artifacts or limitations may exist that affect the quality of the image.
  • Effects include, but are not limited to, poor resolution, motion or blurring artifacts, high noise, low contrast of tissue, poor perfusion, partial volume effect, distortion, clipping of structures, shadowing, etc. Since these quality issues may affect the performance and accuracy of models and simulations based on the imaging data, there is a need to determine if image quality is suitable or to determine the effect of image quality on modeling and simulation results.
  • One method includes receiving one or more images of at least a portion of the patient's anatomy; determining, using a processor of the computer system, one or more image properties of the received images; performing, using a processor of the computer system, anatomic localization or modeling of at least a portion of the patient's anatomy based on the received images; obtaining an identification of one or more image characteristics associated with an anatomic feature of the patient's anatomy based on the anatomic localization or modeling; and calculating, using a processor of the computer system, an image quality score based on the one or more image properties and the one or more image characteristics.
  • One system includes a digital storage device storing instructions for assessing the quality of medical images of at least a portion of a patient's anatomy; and a processor configured to execute the instructions to perform a method including: receiving one or more images of at least a portion of the patient's anatomy; determining, using a processor of the computer system, one or more image properties of the received images; performing, using a processor of the computer system, anatomic localization or modeling of at least a portion of the patient's anatomy based on the received images; obtaining an identification of one or more image characteristics associated with an anatomic feature of the patient's anatomy based on the anatomic localization or modeling; and calculating, using a processor of the computer system, an image quality score based on the one or more image properties and the one or more image characteristics.
  • a non-transitory computer readable medium for use on at least one computer system containing computer-executable programming instructions for assessing the quality of medical images of at least a portion of a patient's anatomy, that when executed by the at least one computer system, cause the performance of a method comprising: receiving one or more images of at least a portion of the patient's anatomy; determining, using a processor of the computer system, one or more image properties of the received images; performing, using a processor of the computer system, anatomic localization or modeling of at least a portion of the patient's anatomy based on the received images; obtaining an identification of one or more image characteristics associated with an anatomic feature of the patient's vasculature based on the anatomic localization or modeling; and calculating, using a processor of the computer system, an image quality score based on the one or more image properties and the one or more image characteristics.
  • FIG. 1 is a schematic diagram of a system for determining various information relating to coronary blood flow in a specific patient, according to an exemplary embodiment
  • FIG. 2 is a flow chart of a method for determining various information relating to coronary blood flow in a specific patient, according to an exemplary embodiment
  • FIG. 3 is a flow chart that describes an exemplary method for assessing medical image quality, generating image quality metrics, and using image quality metrics, according to various exemplary embodiments;
  • FIG. 4 is a flow chart that describes an exemplary method for enabling and performing user-guided assessment of medical image quality, according to an exemplary embodiment
  • FIG. 5 is a flow chart that describes an exemplary process for performing computer-automated assessment of medical image quality, generation of image quality metrics, and use of image quality metrics, according to various exemplary embodiments;
  • FIG. 6 is a flow chart that describes an exemplary process for assessing medical image quality, generating image quality metrics, and using image quality metrics, in the context of estimating coronary fractional flow reserve values, according to various exemplary embodiments;
  • FIG. 7A is an exemplary box plot of fractional flow reserve error and acceptance or rejection based on CT image quality review, according to various exemplary embodiments
  • FIG. 7B is an exemplary box plot of fractional flow reserve error and scoring based on CT image quality review, according to various exemplary embodiments.
  • FIG. 8 is an exemplary bar graph depicting comparisons between performance or accuracy of fractional flow reserve and computed tomography, based on image quality, by number of vessels, according to various exemplary embodiments;
  • FIG. 9 is a table depicting an exemplary rubric for scoring image characteristics based on lumen features of cardiovascular vessels, according to various exemplary embodiments.
  • FIG. 10 is a screenshot of an exemplary interface for displaying computed tomography quality ratings vs. benchmark performance, according to various exemplary embodiments.
  • the present disclosure relates to assessing and quantifying the quality of medical images.
  • the present disclosure describes systems and methods for assessing image quality for the purpose of predicting or analyzing the accuracy and performance of medical imagery simulation and modeling.
  • a method of assessing medical image quality includes: receiving image data and possibly patient information; performing assessment of image quality by computer automated, user-guided, or a combination of means at a local and/or global level; and generating image quality metrics that are regional (e.g., for a vessel) or for an entire dataset or multiple datasets.
  • a method of assessing medical image quality may include applying image quality metrics for one or more of: (i) evaluating whether imaging data is suitable to achieve desired simulation accuracy, precision, and/or performance; (ii) estimating the accuracy, precision, or confidence of simulation results; (iii) guiding simulation or modeling techniques best suited to achieve desired accuracy, precision, and/or performance; and/or (iv) selecting, combining, or correcting the best data from a variety of received data in order to achieve desired accuracy, precision, and/or performance.
  • quality issues or anomalies may include, but are not limited to, low contrast, noise, motion or blurring, misregistration or misalignment, low resolution, partial volume effect, beam hardening, clipped anatomy excluded from the scan, streaking, scanner failures, missing data, and/or inconsistent contrast timing. If these issues affect information of interest, such as the anatomy of coronary arteries, in such a manner that they may affect the quality, accuracy, or performance of blood flow models and simulations, then it may be desirable to detect and score the image quality issues. Then, the quality of the imaging data may be analyzed for its effect on the ability to extract the desired information from patient images.
  • the disclosed methods and systems involve the use of at least one computer configured to receive patient-specific imaging data containing at least some of the coronary vasculature.
  • at least some portions of the coronary artery anatomy may be measured, modeled, segmented, or estimated.
  • at least some portions of the heart, aorta, myocardium, ventricles, valves, veins and other structures of the heart may be measured, modeled, segmented, or estimated.
  • information regarding contrast levels, contrast gradients, or other image-analysis metrics may be extracted to inform the model.
  • Such an embodiment may include the assessment of coronary computed topographic angiography (cCTA) imaging data to simulate information including, but not limited to, coronary blood flow, velocity, pressure, plaque and wall stress, and fractional flow reserve (FFR).
  • CCTTA coronary computed topographic angiography
  • FFR fractional flow reserve
  • the methods and systems may be adopted to other areas of the vasculature including, but not limited to, carotid, peripheral, abdominal, renal, and cerebral, as well as to other imaging modalities including, but not limited to, MRI, PET, SPECT, ultrasound, and angiography.
  • systems and methods for assessing and quantifying image quality are described, for purposes of example, in the context of images of coronary vasculature. More specifically, in certain embodiments, systems and methods for assessing and quantifying image quality are described, for purposes of example, in the context of analyzing the quality of images used in modeling patient-specific coronary vasculature, and simulating blood flow through patient-specific coronary vasculature.
  • the presently disclosed techniques for assessing and quantifying image quality are equally applicable to evaluating and manipulating medical imagery in relation to any anatomy, or in relation to any cardiovascular evaluation, among any other medical diagnostic techniques.
  • the present disclosure relates to methods and systems for assessing image quality in the context of determining blood flow information in a specific patient, using information retrieved from the patient noninvasively.
  • Various embodiments of such a method and system are described in greater detail in U.S. Pat. No. 8,315,812, filed Jan. 25, 2011, and entitled “Method and System for Patient-Specific Modeling of Blood Flow,” which is hereby incorporated by reference in its entirety.
  • the information determined by the method and system may relate to blood flow in the patient's coronary vasculature.
  • the determined information may relate to blood flow in other areas of the patient's vasculature, such as carotid, peripheral, abdominal, renal, and cerebral vasculature.
  • the coronary vasculature includes a complex network of vessels ranging from large arteries to arterioles, capillaries, venules, veins, etc.
  • the coronary vasculature circulates blood to and within the heart and includes an aorta that supplies blood to a plurality of main coronary arteries (e.g., the left anterior descending (LAD) artery, the left circumflex (LCX) artery, the right coronary (RCA) artery, etc.), which may further divide into branches of arteries or other types of vessels downstream from the aorta and the main coronary arteries.
  • aorta that supplies blood to a plurality of main coronary arteries
  • LCX left circumflex
  • RCA right coronary
  • the exemplary method and system may determine information relating to blood flow within the aorta, the main coronary arteries, and/or other coronary arteries or vessels downstream from the main coronary arteries.
  • the aorta and coronary arteries are discussed below, the disclosed method and system may also apply to other types of vessels.
  • the information determined by the disclosed methods and systems may include, but is not limited to, various blood flow characteristics or parameters, such as blood flow velocity, pressure (or a ratio thereof), flow rate, and FFR at various locations in the aorta, the main coronary arteries, and/or other coronary arteries or vessels downstream from the main coronary arteries.
  • This information may be used to determine whether a lesion is functionally significant and/or whether to treat the lesion.
  • This information may be determined using information obtained noninvasively from the patient. As a result, the decision whether to treat a lesion may be made without the cost and risk associated with invasive procedures.
  • FIG. 1 shows aspects of a system for providing information relating to coronary blood flow in a specific patient, according to an exemplary embodiment.
  • a three-dimensional model 10 of the patient's anatomy may be created using data obtained noninvasively from the patient as will be described below in more detail. Other patient-specific information may also be obtained noninvasively.
  • the portion of the patient's anatomy that is represented by the three-dimensional model 10 may include at least a portion of the aorta and a proximal portion of the main coronary arteries (and the branches extending or emanating therefrom) connected to the aorta.
  • Various physiological laws or relationships 20 relating to coronary blood flow may be deduced, e.g., from experimental data as will be described below in more detail.
  • a plurality of equations 30 relating to coronary blood flow may be determined as will be described below in more detail.
  • the equations 30 may be determined and solved using any numerical method, e.g., finite difference, finite volume, spectral, lattice Boltzmann, particle-based, level set, finite element methods, etc.
  • the equations 30 can be solved to determine information (e.g., pressure, velocity, FFR, etc.) about the coronary blood flow in the patient's anatomy at various points in the anatomy represented by the model 10 .
  • the equations 30 may be solved using a computer system 40 .
  • the computer system 40 may output one or more images or simulations indicating information relating to the blood flow in the patient's anatomy represented by the model 10 .
  • the image(s) may include a simulated blood pressure model 50 , a simulated blood flow or velocity model 52 , a computed FFR (cFFR) model 54 , etc., as will be described in further detail below.
  • the simulated blood pressure model 50 , the simulated blood flow model 52 , and the cFFR model 54 provide information regarding the respective pressure, velocity, and cFFR at various locations along three dimensions in the patient's anatomy represented by the model 10 .
  • cFFR may be calculated as the ratio of the blood pressure at a particular location in the model 10 divided by the blood pressure in the aorta, e.g., at the inflow boundary of the model 10 , under conditions of increased coronary blood flow, e.g., conventionally induced by intravenous administration of adenosine.
  • the computer system 40 may include one or more non-transitory computer-readable storage devices that store instructions that, when executed by a processor, computer system, etc., may perform any of the actions described herein for providing various sources of information relating to blood flow in the patient.
  • the computer system 40 may include a desktop or portable computer, a workstation, a server, a personal digital assistant, or any other computer system.
  • the computer system 40 may include a processor, a read-only memory (ROM), a random access memory (RAM), an input/output (I/O) adapter for connecting peripheral devices (e.g., an input device, output device, storage device, etc.), a user interface adapter for connecting input devices such as a keyboard, a mouse, a touch screen, a voice input, and/or other devices, a communications adapter for connecting the computer system 40 to a network, a display adapter for connecting the computer system 40 to a display, etc.
  • the display may be used to display the three-dimensional model 10 and/or any images generated by solving the equations 30 , such as the simulated blood pressure model 50 , the simulated blood flow model 52 , and/or the cFFR model 54 .
  • FIG. 2 shows aspects of a method 60 for providing various sources of information relating to blood flow in a specific patient, according to another exemplary embodiment.
  • the method may include obtaining patient-specific anatomical data, such as information regarding the patient's anatomy (e.g., at least a portion of the aorta and a proximal portion of the main coronary arteries (and the branches extending therefrom) connected to the aorta), and preprocessing the data (step 62 ).
  • the patient-specific anatomical data may be obtained noninvasively, e.g., by CCTA.
  • a three-dimensional model of the patient's anatomy may be created based on the obtained anatomical data (step 64 ).
  • the three-dimensional model may be the three-dimensional model 10 of the patient's anatomy described above in connection with FIG. 1 .
  • the three-dimensional model may be prepared for analysis and boundary conditions may be determined (step 66 ).
  • the three-dimensional model 10 of the patient's anatomy described above in connection with FIG. 1 may be trimmed and discretized into a volumetric mesh, e.g., a finite element or finite volume mesh.
  • the volumetric mesh may be used to generate the equations 30 described above in connection with FIG. 1 .
  • Boundary conditions may also be assigned and incorporated into the equations 30 described above in connection with FIG. 1 .
  • the boundary conditions provide information about the three-dimensional model 10 at its boundaries, e.g., inflow boundaries, outflow boundaries, vessel wall boundaries, etc.
  • the inflow boundaries may include the boundaries through which flow is directed into the anatomy of the three-dimensional model, such as at an end of the aorta near the aortic root.
  • Each inflow boundary may be assigned, e.g., with a prescribed value or field for velocity, flow rate, pressure, or other characteristic, by coupling a heart model and/or a lumped parameter model to the boundary, etc.
  • the outflow boundaries may include the boundaries through which flow is directed outward from the anatomy of the three-dimensional model, such as at an end of the aorta near the aortic arch, and the downstream ends of the main coronary arteries and the branches that extend therefrom.
  • Each outflow boundary can be assigned, e.g., by coupling a lumped parameter or distributed (e.g., a one-dimensional wave propagation) model.
  • the prescribed values for the inflow and/or outflow boundary conditions may be determined by noninvasively measuring physiologic characteristics of the patient, such as, but not limited to, cardiac output (the volume of blood flow from the heart), blood pressure, myocardial mass, etc.
  • the vessel wall boundaries may include the physical boundaries of the aorta, the main coronary arteries, and/or other coronary arteries or vessels of the three-dimensional model 10 .
  • the computational analysis may be performed using the prepared three-dimensional model and the determined boundary conditions (step 68 ) to determine blood flow information for the patient.
  • the computational analysis may be performed with the equations 30 and using the computer system 40 described above in connection with FIG. 1 to produce the images described above in connection with FIG. 1 , such as the simulated blood pressure model 50 , the simulated blood flow model 52 , and/or the cFFR model 54 .
  • the method may also include providing patient-specific treatment options using the results (step 70 ).
  • the three-dimensional model 10 created in step 64 and/or the boundary conditions assigned in step 66 may be adjusted to model one or more treatments, e.g., placing a coronary stent in one of the coronary arteries represented in the three-dimensional model 10 or other treatment options.
  • the computational analysis may be performed as described above in step 68 in order to produce new images, such as updated versions of the blood pressure model 50 , the blood flow model 52 , and/or the cFFR model 54 . These new images may be used to determine a change in blood flow velocity and pressure if the treatment option(s) are adopted.
  • the systems and methods disclosed herein may be incorporated into a software tool accessed by physicians to provide a noninvasive means to quantify blood flow in the coronary arteries and to assess the functional significance of coronary artery disease.
  • physicians may use the software tool to predict the effect of medical, interventional, and/or surgical treatments on coronary artery blood flow.
  • the software tool may prevent, diagnose, manage, and/or treat disease in other portions of the cardiovascular system including arteries of the neck (e.g., carotid arteries), arteries in the head (e.g., cerebral arteries), arteries in the thorax, arteries in the abdomen (e.g., the abdominal aorta and its branches), arteries in the arms, or arteries in the legs (e.g., the femoral and popliteal arteries).
  • the software tool may be interactive to enable physicians to develop optimal personalized therapies for patients.
  • the software tool may be incorporated at least partially into a computer system, e.g., the computer system 40 shown in FIG. 1 used by a physician or other user.
  • the computer system may receive data obtained noninvasively from the patient (e.g., data used to create the three-dimensional model 10 , data used to apply boundary conditions or perform the computational analysis, etc.).
  • the data may be input by the physician or may be received from another source capable of accessing and providing such data, such as a radiology or other medical lab.
  • the data may be transmitted via a network or other system for communicating the data, or directly into the computer system.
  • the software tool may use the data to produce and display the three-dimensional model 10 or other models/meshes and/or any simulations or other results determined by solving the equations 30 described above in connection with FIG. 1 , such as the simulated blood pressure model 50 , the simulated blood flow model 52 , and/or the cFFR model 54 .
  • the software tool may perform steps 62 - 70 .
  • the physician may provide further inputs to the computer system to select possible treatment options, and the computer system may display to the physician new simulations based on the selected possible treatment options.
  • each of steps 62 - 70 shown in FIG. 2 may be performed using separate software packages or modules.
  • the software tool may be provided as part of a web-based service or other service, e.g., a service provided by an entity that is separate from the physician.
  • the service provider may, for example, operate the web-based service and may provide a web portal or other web-based application (e.g., run on a server or other computer system operated by the service provider) that is accessible to physicians or other users via a network or other methods of communicating data between computer systems.
  • the data obtained noninvasively from the patient may be provided to the service provider, and the service provider may use the data to produce the three-dimensional model 10 or other models/meshes and/or any simulations or other results determined by solving the equations 30 described above in connection with FIG.
  • the web-based service may transmit information relating to the three-dimensional model 10 or other models/meshes and/or the simulations so that the three-dimensional model 10 and/or the simulations may be displayed to the physician on the physician's computer system.
  • the web-based service may perform steps 62 - 70 and any other steps described below for providing patient-specific information.
  • the physician may provide further inputs, e.g., to select possible treatment options or make other adjustments to the computational analysis, and the inputs may be transmitted to the computer system operated by the service provider (e.g., via the web portal).
  • the web-based service may produce new simulations or other results based on the selected possible treatment options, and may communicate information relating to the new simulations back to the physician so that the new simulations may be displayed to the physician.
  • the present disclosure describes methods and systems for quantifying and assessing the effects of image quality of the available data on the anatomic and mathematical models used in simulating blood flow characteristics.
  • the present disclosure describes methods and systems for assessing the uncertainty of vessel and other anatomic models based on local and global image properties; and computing confidence intervals of simulated blood flow calculations based on predicted uncertainty.
  • methods and systems may implement at least one computer configured to detect and score image quality issues.
  • coronary imaging data is analyzed by a combination of automated and user-guided methods using at least one computer system.
  • the disclosed methods and systems may be fully automated, fully user-guided, or both automated and user-guided.
  • the disclosed methods and systems may be configured to perform an assessment that may include an evaluation or quantification of one or more of the potential image quality issues listed below:
  • these issues may be detected at a global level, local level, or both global and local levels.
  • a global level issue may involve detecting an image quality issue based on the entire image volume, and may in some cases be referred to as an “image property.”
  • a local level issue may involve the detection space of a particular region, e.g., around some or all of the coronary arteries, coronary plaque, along one or more vessel centerlines, etc., and may in some cases be referred to as an “image characteristic.”
  • systems and methods for determining and assessing image quality may use a combination of automated and user-guided quantitative and qualitative assessment of the local and global image quality issues, based on the previously mentioned quality issues.
  • Image quality issues may come from a plurality of sources including: (i) physical-based sources, such as from tube (kVP, mA) and photons (fluctuation, starvation), beam hardening (streaks, dark bands, etc.), partial volume (blooming), undersampling (blooming), and gantry rotation speed; (ii) patient-based sources, such as heart rate, regular rhythm (motion), metal material, and BMI (beam hardening); (iii) scanner-based sources, such as detector array entities out of calibration, or reconstruction kernels and methods; and/or (iv) protocol-based sources, such as Beta blockers administration (to lower HR), contrast agent administration (high concentration, flow rate, single, dual, triple phase), contrast timing control, etc., ECG sync and correction, nitroglycerin (to enlarge vessel and increase opacification), and left vs. left+right heart opacification.
  • sources including: (i) physical-based sources, such as from tube (kVP
  • FIG. 3 is a flow chart that describes an exemplary method 100 for assessing medical image quality, generating image quality metrics, and using image quality metrics, according to various exemplary embodiments.
  • method 100 includes receiving patient image data (step 102 ).
  • step 102 may include implementing at least one computer system for determining image quality for simulation and modeling by receiving patient-specific data regarding the patient's body, organs, tissue, or portion thereof.
  • step 102 may include obtaining patient-specific data 10 at computer system 40 , or any other computational system (which may be, but is not limited to: a computer, laptop, mobile phone, mobile tablet, DSP, cloud computing system, server farm, etc.).
  • Method 100 may include performing automated, user-guided, or combined automated and user-guided assessment of local and/or global quality of the received image data (step 104 ).
  • a computer system may automatically determine both global quality assessments of an entire image or group of images, and local quality assessments of specific portions of a single image or portions of a patient's imaged anatomy.
  • a computer system may prompt a user to determine and enter global quality assessments of an entire image or group of images, and determine local quality assessments of specific portions of a single image or portions of a patient's imaged anatomy.
  • certain aspects of the local and/or global quality assessments may be formed by any combination of automated and user-guided assessment.
  • the at least one computer system and method may assess or score a single, various, or combinations of features of image quality to generate image quality metrics for regions of interest or for an entire image dataset (step 106 ). Specifically, the at least one computer system may use the scores to formulate a regional or dataset image quality metric based on the evaluated features of image quality. The at least one computer system may use the results of the image quality assessment as an input to perform modeling or simulation with the patient-specific data. However, in addition to modeling and simulation of patient-specific data, such as blood flow, the image quality metrics may be used as inputs for any other activities or assessments.
  • method 100 may include using the generated metrics to evaluate if imaging data is suitable to achieve a desired simulation accuracy (step 108 ).
  • method 100 may include using the results of the image quality assessment to accept or reject the image data for modeling or simulation based on predetermined criteria related to accuracy, precision, performance, or other requirements.
  • method 100 may include using the results of the image quality assessment to estimate performance metrics (e.g., time to complete analysis, cost of analysis) or make a decision based on those metrics to perform or not perform modeling or simulation with the patient-specific data using at least one computer system.
  • a computer system may compute and display a time to complete analysis, based on the results of the image quality assessment.
  • the computer system may compute and display a cost of analysis, based on the results of the image quality assessment.
  • the computer system may display and/or transmit a recommendation or requirement to perform or not perform modeling or simulation with the patient-specific data using at least one computer system, based on the results of the image quality assessment. Any of such computed information, such as computed time to complete analysis, cost of analysis, and/or perform/not perform analysis may be displayed to a physician, technician, or any other healthcare provider, whether through an electronic display and/or over an electronic network.
  • method 100 may include using the generated metrics to estimate accuracy or confidence in simulation results (step 110 ).
  • method 100 may include using the results of the image quality assessment to perform modeling or simulation, and output results with a confidence metric (e.g., errors, percent confidence, confidence intervals, accuracy or precision estimates) associated with the simulation results.
  • a confidence metric e.g., errors, percent confidence, confidence intervals, accuracy or precision estimates
  • method 100 may include using the generated metrics to guide simulation techniques best suited to achieve desired simulation accuracy (step 112 ).
  • method 100 may include using the results of the image quality assessment to model or simulate using different techniques or algorithms in the entire image data set or relevant affected portions depending on the image quality assessment to enhance or achieve desired performance, accuracy, precision, or other requirements.
  • method 100 may include using the generated metrics to select, combine, or correct best available data to achieve desired simulation accuracy from a plurality of options received (step 114 ).
  • method 100 may include using the results of the image quality assessment to correct for image quality issues prior to performing modeling or simulation, to enhance or achieve desired performance, accuracy, precision, or other requirements.
  • method 100 may include using the results of the image quality assessment to select the dataset from a multitude of available data (e.g., alternate series or reconstructions) that is most appropriate for performing modeling or simulation, to enhance or achieve desired performance, accuracy, precision, or other requirements.
  • method 100 may include using the results of the image quality assessment to combine various pieces of different imaging data (e.g., other phases or other reconstructions or modalities) to compensate for image quality issues and perform modeling or simulation with the patient-specific data using at least one computer system, to enhance or achieve desired performance, accuracy, precision, or other requirements.
  • imaging data e.g., other phases or other reconstructions or modalities
  • method 100 may include using the generated metrics to provide feedback to obtain better image quality to achieve desired accuracy (step 116 ).
  • method 100 may include using the results of the image quality assessment to assess or score a single, various, or combination of features of image quality in a timeframe that allows feedback to be provided to the personnel providing the imaging data such that they could correct, redo, or update the imaging data to meet some predefined criteria to enhance or achieve desired performance, accuracy, precision, or other requirements.
  • the at least one computer system and method may perform one or more additional iterations of modeling or simulation.
  • FIG. 4 is a flow chart that describes an exemplary method 120 for performing user-guided assessment of image quality, according to an exemplary embodiment.
  • method 120 may include receiving patient anatomical image data (step 122 ).
  • step 122 may include obtaining image data 10 at a computer system 40 , consistent with any of the disclosure of FIGS. 1 and 2 above.
  • Method 120 may further include determining one or more centerlines of patient vasculature (step 124 ).
  • step 124 may include using a processor of computer system 40 to automatically identify one or more centerlines of patient vasculature, consistent with any of the disclosure of FIGS. 1 and 2 above.
  • the processor of computer system 40 may add centerlines to the primary vessels (RCA, LAD, and LCX), or any other vessels greater than 2 mm in diameter.
  • Method 120 may further include prompting a user to input image quality issues, image anomalies, image artifacts, or other “regions of uninterpretability” along each centerline using a set of visual criteria (e.g., blur, motion, image artifacts, etc.) (step 126 ).
  • a processor of computer system 40 may initiate the display of one or more images and centerlines, and prompt a user to review and inspect the images, and to enter inputs of image quality issues upon finding any misregistration artifacts, blurring, stents, undesirable contrast-to-noise ratio, motion artifacts, blooming artifacts, calcium, scanner errors, missing slices, incomplete data, and so on.
  • the processor of computer system 40 may generate user interface elements that a user can manipulate to indicate that the user identifies any of the image quality issues described herein, along with certain characteristics of location, quantity, or extent of those issues.
  • either the user or the processor of computer system 40 may characterize each region of uninterpretability as being either short (e.g., 0-5 mm) or long (e.g., greater than 5 mm).
  • users may be prompted to identify contrast timing and noise as “good” if an image exhibits high contrast, low noise, and mild right contrast; as “marginal” if an image exhibits moderate contrast, noise, and high right contrast; and as “poor” if an image exhibits low contrast, high noise, and high right contrast.
  • users may be prompted to identify misregistration as “good” if an image exhibits no misregistration affecting lumen geometry; as “marginal” if an image exhibits misregistration artifacts that are nearly perpendicular to the vessel and can be corrected; and as “poor” if an image exhibits misregistration that cannot be corrected or that exists in an area of disease such that the lumen cannot be determined.
  • users may be prompted to identify motion as “good” if the motion does not affect the lumen or plaque; as “marginal” if the image reflects that the lumen is affected, but the vessel can be interpreted and modeled with assumptions; and as “poor” if the image reflects that the lumen interpretability is severely affected by motion.
  • users may be prompted to identify blooming as “good” if mild blooming does not affect lumen interpretability; as “marginal” if a high degree of blooming may require correction but the image still retains lumen visibility; and as “poor” if severe blooming artifact completely obscures the lumen.
  • Method 120 may further include receiving or calculating a score for each region of uninterpretability based on the length of the region (step 128 ).
  • scores for image quality issues may be determined and analyzed for how they impact or predict modeling and simulation accuracy, precision, and performance.
  • the image quality assessment may have absolute failure criteria in which a dataset is deemed unacceptable, it may have various metrics that are scored, combined, and weighted over a region, vessel, or entire dataset, or it may have a combination of both.
  • an automatic fail may be triggered whenever some single or combined image quality issue(s) results in 25% or more of an artery being indiscernible (whether due to noise, motion, blooming, poor contrast, misregistration, etc.).
  • metrics may be generated for either a region (e.g., vessel) or dataset by the image quality scoring system and method based on ratings of at least some of the image quality issues described previously.
  • each region of uninterpretability may receive a score based on length (e.g., in one embodiment: 1.5 for short, and 3 for long).
  • a score to reject a patient's images i.e., a “case” may involve a score of 6 for a single main vessel, a score of 8 for an entire case, and/or a so-called “red flag” that has been assigned a score of 10.
  • FIG. 9 depicts a table of an exemplary rubric for scoring image characteristics based on lumen features of cardiovascular vessels, according to various exemplary embodiments. Specifically, FIG. 9 depicts one exemplary embodiment of a scoring rubric for assigning scores to regions of uninterpretability or other image quality issues. For example, as shown in the exemplary rubric of FIG.
  • a different score may be assigned to each characteristic (i.e., either combination (noise, motion, contrast), motion, mis-alignment, noise, blooming, contrast, or opacification) based on an amount of region affected (e.g., “full” or “small,” or “long” or “short”), and based on whether the identified characteristic: (i) completely obliterates the lumen or causes missing information and prevents identification of disease; (ii) prevents determination of precise lumen boundary, but enables identification of disease present (e.g., shows where minimal luminal diameter (“MLD”) would be); or (iii) prevents determination of precise lumen boundary and prevents identification of disease. It should be appreciated that the scoring rubric of FIG.
  • scoring system 9 is only an example, and that any alternative scoring mechanisms are contemplated within the scope of this disclosure.
  • the scoring system may be inverted such that lower scores indicate lower image quality, whereas higher scores indicate higher image quality.
  • the scoring system may be based on an exponential, logarithmic, or fractional scale.
  • the scoring system may be generated based on a color-coded and/or letter-grade scale, where a color and/or letter indicates some quality level of the scored images.
  • the image quality scores may be weighted and combined with other factors including but not limited to: magnitude of effect, size of the issue, regions affected, issue type (e.g., noise or motion), presence/absence of disease, vessel size, location in the heart, uncertainty in lumen definition, combination with other issues, visual interpretability, algorithm confidence, etc.
  • issue type e.g., noise or motion
  • a function for regions or datasets may be derived that use some, all, or additional weighting factors.
  • Quality region f ( ⁇ i vessel issue i *magnitude*type*disease*size*vesselsize*location*lumenuncertainty)
  • Quality dataset f ( ⁇ i dataset issue i *magnitude*type*disease*size*vesselsize*location*lumenuncertainty)
  • limits may be defined for the following criteria, and unacceptable scores may result in rejections of data for coronary blood flow modeling and simulations:
  • the following criteria may be defined at a local level. For example, for each image quality issue, a score of magnitude of the effect may be generated. Other information may be added, such as the location and size of the issue, based on the following:
  • Method 120 may further include calculating and outputting a total score of the regions of uninterpretability for the image as a quantitative metric of image quality (step 130 ). For example, in one embodiment, the scores for each issue weighted by size and location may be summed over each vessel and case.
  • FIG. 5 is a flow chart that describes an exemplary method 150 for performing computer-automated assessment of medical image quality, generation of image quality metrics, and use of image quality metrics, according to various exemplary embodiments.
  • method 150 may include receiving patient anatomical image data, and generating a vessel model of patient vasculature (step 152 ).
  • Method 150 may further include determining, using a processor, one or more global image properties (step 154 ).
  • the disclosed systems and methods may involve automatically assessing quantitative information that can be extracted from the imaging data including, but not limited to, the image resolution, slice thickness, reconstruction kernel, number of scanner slices, missing slices or missing data, and phase of acquisition.
  • the information may be extracted by analyzing dimensions or tags in the image data (e.g., DICOM header).
  • DICOM header e.g., DICOM header
  • the resolution, slice, phase, and data completeness may not have absolute accept/reject criteria, but rather a range of scores that will contribute to an overall image quality metric for the dataset.
  • resolution and slice thickness may be combined to obtain a voxel volume (e.g., 0.4 mm ⁇ 0.4 mm ⁇ 0.75 mm). Higher or lower resolutions may add or subtract from an overall dataset score.
  • information regarding medication administered and heart rate during an imaging study may be submitted with the study to the computer system.
  • the computer system may accept/reject a dataset based on this information, e.g., absence of sublingual nitrates may necessitate rejection of the dataset.
  • the presence, absence, or dose of medication, the HR, or other physiologic metrics may contribute to the overall score or direct the method and computer system to perform modeling and simulation with different methods.
  • the absence of sublingual nitrates may direct the use of alternate coronary lumen segmentation algorithms to ensure proper vessel sizes.
  • missing anatomic data, presence of anatomic abnormalities, and presence of implanted devices or prior surgeries may be detected by a user of the computer system.
  • the presence or absence of these issues may add to a score or result in accept/reject decisions for the dataset.
  • These assessments may also be automated.
  • Method 150 may further include determining, using a processor, one or more centerlines of patient vasculature based on the vessel model (step 156 ). Method 150 may further include determining one or more local image properties at each of a plurality of centerline locations (e.g., blur, motion, contrast, etc.) (step 158 ).
  • the computer system may be configured to automatically determine such local image properties, or local or global image quality, by implementing a fully automated quantitative assessment of the image quality, based on any one or more of the image quality issues described herein.
  • a processor of computer system 40 may automatically determine one or more local image properties in any of the manners discussed above with respect to the user-guided method of FIG. 4 , except that computer system 40 may do so automatically, such as by executing an algorithm, in some cases according to the exemplary concepts described below.
  • the contrast and noise levels may be assessed locally (e.g., at a section of a vessel) or globally (e.g., across multiple vessels or a large representative vessel or structure). This assessment may be performed by taking measurements of the contrast level (e.g., mean contrast in a region of interest) and noise level (e.g., standard deviation of contrast in a region of interest). These measurements may also be combined to create a signal to noise ratio by dividing the contrast and noise measurements. Additionally, the contrast and noise measurements may take into account background or surrounding tissue contrast and noise to represent the difference between the region of interest (e.g., coronary artery) and background data (e.g., myocardium and epicardial fat).
  • region of interest e.g., coronary artery
  • background data e.g., myocardium and epicardial fat
  • a processor of computer system 40 may calculate noise based on an algorithm that receives as inputs some CT volume data and aorta mask data (e.g., from zhf file), and that outputs an aorta mean Hounsfield Unit (“HU”) value, noise standard deviation, surrounding mean HU value, and CNR.
  • HU Hounsfield Unit
  • a processor of computer system 40 may calculate contrast differences between left and right ventricles based on an algorithm that receives as inputs some CT volume and myomass (long axis and segmentation), and that outputs LV mean HU value and RV mean HU value.
  • misregistration or misalignments may be detected by searching through the data or globally through the dataset or locally near the arteries to identify where offsets occur between adjacent images. These may be detected by a user or by the computer system.
  • the degree of misregistration may be classified by the distance the data is shifted, the amount of a region that is affected (e.g., length of vessel that is affected), or by the orientation of the region affected (e.g., perpendicular or parallel to vessel).
  • a processor of computer system 40 may calculate index-slice misregistration based on an algorithm that receives a CT image, outputs peaks locations, and scores values.
  • motion or blurring artifact may be detected by scanning through the global data or locally near the arteries to identify areas where the image data is blurred or has soft edges (e.g., the edge of a vessel has soft and smeared edges). These may be detected by a user or by the computer system.
  • partial volume or blooming artifacts may be detected by scanning through the global data or locally near the arteries to identify areas where the image data contains bright features that interfere with other parts of the data. These may be detected by a user or by the computer system.
  • the degree of blooming may be classified by the intensity, the size, and/or a measurement of how far it spreads into neighboring structures (e.g., how much does blooming cover the lumen).
  • beam hardening may be detected by scanning through the data globally or locally near the arteries to identify areas where the image data contains dark spots or streaks that interfere with other parts of the data. These may be detected by a user or by the computer system.
  • the degree of beam hardening may be classified by the intensity, the shape, and/or a measurement of how much it interferes with neighboring structures (e.g., how much does beam hardening obscure the lumen).
  • Method 150 may further include predicting local uncertainty in the vessel model based on the local and global image properties (step 160 ). For example, in certain embodiments, machine learning, regression, and other statistical techniques may be used to derive functions or models relating image quality to modeling, simulation, and performance. As described in the next section, these metrics may be adjusted to achieve different needs.
  • Method 150 may further include using the local uncertainty prediction to compute a confidence interval of a simulated blood flow calculation (step 162 ). Method 150 may further include calculating and outputting a total uncertainty for the vessel model as a quantitative metric of image quality (step 164 ).
  • metrics may be tuned and have various correlations or criteria associated with them to achieve purposes including but not limited to: assess sufficiency of data for automated modeling, assess sufficiency of data for user-guided interpretation and/or modeling, direct the method or system used to model data, accept/reject imaging data, determine which of a multitude of a received data is best for modeling (e.g., alternate phases or reconstructions), provide feedback on imaging data in order to obtain improved or corrected data, label results differently depending on the image quality scores, and provide confidence estimation depending on the uncertainty associated with the image quality issues. All of these purposes are within the context of measuring and predicting simulation and modeling accuracy, precision, and performance.
  • criteria may be derived for relating the image quality metric to error of FFR simulation results versus a reference standard of measured FFR. Coronary vessels and/or full datasets that pass the criteria may be accepted for processing in order to ensure a certain level of accuracy and precision of the solution. Vessels or full datasets that fail the criteria may be correlated with having higher error than desired. Alternatively, vessels or full datasets that fail may be directed to other methods and or systems that can achieve higher accuracy.
  • criteria may be derived relating the image quality metric to variability in simulated FFR results based on different users. Coronary vessels and/or full datasets that pass the criteria may be accepted for processing in order to ensure a certain level of precision of the solution. Vessels or full datasets that fail the criteria may be correlated with having higher variability than desired. Alternatively, vessels or full datasets that fail may be directed to other methods and or systems that can achieve higher precision.
  • criteria may be derived relating the image quality metric to performance efficiency of modeling and simulating blood flow. Datasets above certain scores may be rejected, associated with a special processing fee, or may be directed to different resources to obtain a desired efficiency.
  • an estimate of simulation cost and/or time may be provided based on the image quality score. For example, if the image quality is getting worse and worse, it may be possible to estimate higher cost or price associated with manually identifying and correcting image quality characteristics or anatomic characteristics.
  • criteria may be derived to label results from FFR simulations that are performed in coronary vessels and/or full datasets that contain a region of low image quality that fails to meet the criteria.
  • Such labels may serve to provide indication that there is uncertainty in the solution in that region of the model and/or to explain what is modeled in light of the uncertainty (e.g., an assumption).
  • criteria may be derived to label regions in models that require special processing to ensure accuracy (e.g., inspection, different algorithm, expert review).
  • criteria may be set to use certain methods in determining vessel size in the presence of certain image quality issues. For example, when a blooming artifact around calcified plaque is present, methods and systems for determining the lumen boundary (and subsequently blood flow) near the artifact may differ from those in the absence of artifact.
  • criteria may be derived to assess the uncertainty or confidence of FFR simulation results that are performed in coronary vessels and/or full datasets that contained a region of low image quality that failed to meet the criteria.
  • the uncertainty or confidence may result in the FFR results being reported with a % confidence or a confidence interval based on the effect of image quality (e.g., FFR is 0.87+/ ⁇ 0.05 or FFR is ⁇ 0.80 with 76% confidence).
  • criteria may be derived relating the image quality metric to error of FFR simulation results versus a reference standard of measured FFR. Coronary vessels and/or full datasets may be ranked on their scores against this criteria to determine which of a multitude of data would be best for simulating FFR results and obtaining the highest accuracy.
  • At least one computer system may be located or rapidly accessible from the site where imaging data is created. Criteria may be set to assess the image quality as it relates to impacting or predicting FFR simulation results. Coronary vessels and/or full datasets may be ranked on their scores against this criteria to provide instant feedback such that the site creating the imaging data could correct or update data until it meets the criteria needed to obtain desirable accuracy. Alternatively, instant feedback could be provided with an estimate or confidence associated with a reduced accuracy, allowing the site creating the imaging data to accept a lower accuracy if there is clinical benefit.
  • FIG. 6 is a flow chart that describes an exemplary method 200 for assessing medical image quality, generating image quality metrics, and using image quality metrics, in the context of estimating coronary fractional flow reserve values, according to various exemplary embodiments.
  • FIG. 6 depicts a method of estimating coronary fractional flow reserve (FFR) values based on certain image quality assessment techniques disclosed herein, and FFR calculation techniques described in U.S. Pat. No. 8,315,812.
  • FFR coronary fractional flow reserve
  • method 200 may begin by selecting a particular patient (step 202 ) and receiving patient image and physiologic data (step 204 ).
  • Method 200 may include validating the received imagery and data with known patient information (step 206 ), for example, for user identity or privacy reasons.
  • Method 200 may include determining whether the received data is acceptable (step 208 ).
  • step 208 may include either accepting or rejecting each of one or more received images based on any one or combination of the image assessment and scoring techniques disclosed herein. If any one or more images are rejected, method 200 may include generating a rejection report (step 210 ).
  • the method may include obtaining images that are rejected and providing feedback to the user on the rejected images, to assist the user in obtaining new images that would not be rejecting.
  • the computer system may send to a technician, physician, or any other healthcare professional, a report of rejected images along with guidelines and/or recommendations for adjusting image acquisition parameters that would enable obtaining images of higher image quality scores.
  • a report of rejected images may be displayed to a physician, technician, or any other healthcare provider, whether through an electronic display and/or over an electronic network.
  • method 200 may include performing radiologic workstation pre-processing and assessment of data (step 212 ). Method 200 may then include calculating myocardial mass (step 214 ), generating an initial tree of coronary vessels and branches (step 216 ), finding one or more vessel lumen edges (step 218 ), matching thresholds in main vessels to edge segmentations (step 220 ), and detecting, segmenting, removing, and smoothing any plaque or calcium (step 222 ). Method 200 may then include determining whether segmentation succeeded using an algorithm (step 224 ). If not, then method 200 may include manually segmenting or correcting the segmentation (step 226 ). If segmentation succeeded, then method 200 may include determining whether independent verification of segmentation is acceptable (step 228 ). If not, then method 200 may return to step 216 of generating the initial tree of coronary vessels and branches.
  • method 200 may include outputting and smoothing a solid model (step 230 ), extracting one or more vessel centerlines (step 232 ), calculating vessel cross-sectional areas (step 234 ), trimming the model (step 236 ), generating a solid model (step 238 ), setting boundary conditions for hyperemia conditions (step 240 ), and generating a final mesh (step 242 ).
  • Method 200 may then include verifying whether mesh and boundary conditions are acceptable (step 244 ). If not, then method 200 may return to step 234 of calculating cross-sectional area.
  • method 200 may include simulating hyperemia flow (step 246 ) and verifying whether the solution result is acceptable (step 248 ). If not, then method 200 may include refining stenosis geometry, correcting boundary conditions, etc. (step 258 ). If the solution result is acceptable (step 248 ; Yes), then method 200 may include extracting cFFR, documenting the same along the vessels, and generating images for a report (step 250 ). Method 200 may then include determining whether independent verification of the final results is acceptable (step 252 ). If not, then method 200 may include returning to step 216 of generating the initial tree of coronary vessels and branches.
  • method 200 may include finalizing a report (step 254 ) and forwarding the finalized report to the physician (step 256 ).
  • FIG. 7A is an exemplary box plot of fractional flow reserve error and acceptance or rejection based on CT image quality review, according to various exemplary embodiments.
  • the box plot of FIG. 7A may illustrate that rejected cases may have more variation of FFRct error than do the accepted cases.
  • FIG. 7B is an exemplary box plot of fractional flow reserve error and scoring based on CT image quality review, according to various exemplary embodiments.
  • the box plot of FIG. 7B may illustrate that variation of FFRct error may increase as an image quality penalty score increases.
  • cases having a score between 7 and 10 may have substantially higher variation in FFRct error than cases having a score between 0 and 1.
  • FIG. 8 is an exemplary bar graph depicting comparisons between quality of fractional flow reserve and computed tomography based on image quality by number of vessels, according to various exemplary embodiments. Specifically, the bar graph of FIG. 8 may depict performance as correlated to vessel-specific quality ratings of CT interpretability.
  • FIG. 10 is an exemplary screenshot depicting computed tomography quality ratings vs. benchmark performance, according to various exemplary embodiments.
  • a processor of computer system 40 may provide a user interface by which a user, such as an image technician, physician, or any other health care provider, may review a CT image quality assessment for each of a plurality of patients or “cases.”
  • a user such as an image technician, physician, or any other health care provider
  • each case may be displayed as having one of “Good,” “Marginal,” or “Poor” image quality.
  • the image quality may also be compared, such as by display in a bar or other chart, with certain benchmark performance standards of image quality.
  • the interface may generate and display quality reports, and/or make recommendations for improving the obtained quality.
  • the user interface may suggest reviewing the “mA/kV settings,” and may provide a link to a tutorial on noise.
  • the user interface and guidelines may provide the user with an assessment of image quality and recommendations for improving image quality in relation to any of the image quality issues discussed herein.
  • the presently disclosed systems and methods may enable the automatic estimation and correction of image quality issues, thereby reducing human time and variability before now associated with quality control review of image data. Moreover, the presently disclosed systems and methods may provide better understanding of a relationship between simulation and modeling accuracy (e.g., FFR error) and image quality scores. Still further, the presently disclosed systems and methods may enable users to better and automatically select a desirable base phase of image for analyst review, and provide better “red flags” for further review or rejection of certain scans.
  • simulation and modeling accuracy e.g., FFR error
  • the presently disclosed techniques may include defining input uncertainties, calculating FFR analysis sensitivities, and calculating confidence intervals in FFR, according to any of the techniques described in U.S. application Ser. No. 13/864,996, filed Apr. 17, 2013, the entirety of which is incorporated herein by reference.
  • the presently disclosed techniques may include performing any of the various presolving techniques described in U.S. application Ser. No. 13/625,628, filed Sep. 24, 2012, the entirety of which is incorporated herein by reference.
  • FFR values may be obtained using machine learning estimates as opposed to physics-based simulations.
  • the disclosed systems and methods may efficiently estimate blood flow characteristics based on knowledge gleaned from analyzing blood flow of numerous other patients.
  • the disclosed systems and methods may include performing any of the various machine learning techniques described in U.S. Provisional Patent Application No. 61/700,213, filed Sep. 12, 2012, the entirety of which is incorporated herein by reference.
  • FFR values may be obtained by training a machine learning algorithm to estimate FFR values for various points of patient geometry based on feature vectors of patient physiological parameters and measured blood flow characteristics, and then applying the machine learning algorithm to a specific patient's geometry and physiological parameters to obtain predicted FFR values.
  • One or more of the steps described herein may be performed by one or more human operators (e.g., a cardiologist or other physician, the patient, an employee of the service provider providing the web-based service or other service provided by a third party, other user, etc.), or one or more computer systems used by such human operator(s), such as a desktop or portable computer, a workstation, a server, a personal digital assistant, etc.
  • the computer system(s) may be connected via a network or other method of communicating data.
  • Every device and apparatus set forth herein may be used in any suitable medical procedure, may be advanced through any suitable body lumen and body cavity, and may be used for imaging any suitable body portion.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Optics & Photonics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Theoretical Computer Science (AREA)
  • Hematology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • General Physics & Mathematics (AREA)
  • Quality & Reliability (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Image Analysis (AREA)
  • Image Processing (AREA)
US14/163,589 2013-03-15 2014-01-24 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics Active US8824752B1 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
US14/163,589 US8824752B1 (en) 2013-03-15 2014-01-24 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,554 US8861820B2 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,536 US8831314B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,594 US8831315B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
CA2904832A CA2904832C (en) 2013-03-15 2014-02-27 Image quality assessment for simulation accuracy and performance
EP14713284.9A EP2803038B1 (en) 2013-03-15 2014-02-27 Image quality assessment for simulation accuracy and performance
KR1020207030780A KR102312011B1 (ko) 2013-03-15 2014-02-27 시뮬레이션 정확도 및 성능을 위한 이미지 품질 평가
CN201480015889.9A CN105051784B (zh) 2013-03-15 2014-02-27 对模拟准确度和性能的图像质量评估
JP2016500462A JP6255473B2 (ja) 2013-03-15 2014-02-27 シミュレーションの正確度および性能に対する画質評価
PCT/US2014/019008 WO2014149496A1 (en) 2013-03-15 2014-02-27 Image quality assessment for simulation accuracy and performance
DE202014010690.8U DE202014010690U1 (de) 2013-03-15 2014-02-27 System zum Bewerten der Qualität medizinischer Bilder wenigstens eines Teils der Anatomie eines Patienten
EP20151462.7A EP3664026B1 (en) 2013-03-15 2014-02-27 Automatically selecting images to produce models for use in patient-specific blood flow simulation
KR1020157026093A KR102172182B1 (ko) 2013-03-15 2014-02-27 시뮬레이션 정확도 및 성능을 위한 이미지 품질 평가
AU2014238124A AU2014238124A1 (en) 2013-03-15 2014-02-27 Image quality assessment for simulation accuracy and performance
DE202014010689.4U DE202014010689U1 (de) 2013-03-15 2014-02-27 System zum Bewerten der Qualität medizinischer Bilder wenigstens eines Teils der Anatomie eines Patienten
US14/484,112 US9008405B2 (en) 2013-03-15 2014-09-11 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/554,653 US9672615B2 (en) 2013-03-15 2014-11-26 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US15/185,668 US9836840B2 (en) 2013-03-15 2016-06-17 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
AU2016222402A AU2016222402B2 (en) 2013-03-15 2016-08-31 Image quality assessment for simulation accuracy and performance
JP2017134438A JP6410891B2 (ja) 2013-03-15 2017-07-10 シミュレーションの正確度および性能に対する画質評価
US15/802,840 US10719931B2 (en) 2013-03-15 2017-11-03 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
JP2018178762A JP6656331B2 (ja) 2013-03-15 2018-09-25 シミュレーションの正確度および性能に対する画質評価
JP2020016765A JP2020080165A (ja) 2013-03-15 2020-02-04 シミュレーションの正確度および性能に対する画質評価
US16/902,721 US11494904B2 (en) 2013-03-15 2020-06-16 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US17/739,558 US11803965B2 (en) 2013-03-15 2022-05-09 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US18/472,729 US20240013388A1 (en) 2013-03-15 2023-09-22 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361793162P 2013-03-15 2013-03-15
US14/163,589 US8824752B1 (en) 2013-03-15 2014-01-24 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US14/172,536 Continuation US8831314B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,594 Continuation US8831315B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,554 Continuation US8861820B2 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics

Publications (2)

Publication Number Publication Date
US8824752B1 true US8824752B1 (en) 2014-09-02
US20140275945A1 US20140275945A1 (en) 2014-09-18

Family

ID=51400051

Family Applications (11)

Application Number Title Priority Date Filing Date
US14/163,589 Active US8824752B1 (en) 2013-03-15 2014-01-24 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,554 Active US8861820B2 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,594 Active US8831315B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,536 Active US8831314B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/484,112 Active US9008405B2 (en) 2013-03-15 2014-09-11 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/554,653 Active 2034-04-29 US9672615B2 (en) 2013-03-15 2014-11-26 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US15/185,668 Active US9836840B2 (en) 2013-03-15 2016-06-17 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US15/802,840 Active 2034-07-18 US10719931B2 (en) 2013-03-15 2017-11-03 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US16/902,721 Active 2034-08-09 US11494904B2 (en) 2013-03-15 2020-06-16 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US17/739,558 Active US11803965B2 (en) 2013-03-15 2022-05-09 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US18/472,729 Pending US20240013388A1 (en) 2013-03-15 2023-09-22 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics

Family Applications After (10)

Application Number Title Priority Date Filing Date
US14/172,554 Active US8861820B2 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,594 Active US8831315B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/172,536 Active US8831314B1 (en) 2013-03-15 2014-02-04 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/484,112 Active US9008405B2 (en) 2013-03-15 2014-09-11 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US14/554,653 Active 2034-04-29 US9672615B2 (en) 2013-03-15 2014-11-26 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US15/185,668 Active US9836840B2 (en) 2013-03-15 2016-06-17 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US15/802,840 Active 2034-07-18 US10719931B2 (en) 2013-03-15 2017-11-03 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US16/902,721 Active 2034-08-09 US11494904B2 (en) 2013-03-15 2020-06-16 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US17/739,558 Active US11803965B2 (en) 2013-03-15 2022-05-09 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US18/472,729 Pending US20240013388A1 (en) 2013-03-15 2023-09-22 Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics

Country Status (9)

Country Link
US (11) US8824752B1 (zh)
EP (2) EP3664026B1 (zh)
JP (4) JP6255473B2 (zh)
KR (2) KR102172182B1 (zh)
CN (1) CN105051784B (zh)
AU (2) AU2014238124A1 (zh)
CA (1) CA2904832C (zh)
DE (2) DE202014010689U1 (zh)
WO (1) WO2014149496A1 (zh)

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140324400A1 (en) * 2013-04-30 2014-10-30 Marquette University Gesture-Based Visualization System for Biomedical Imaging and Scientific Datasets
US20150025330A1 (en) * 2013-07-19 2015-01-22 Volcano Corporation Devices, Systems, and Methods for Assessment of Vessels
US20150242589A1 (en) * 2014-02-25 2015-08-27 Siemens Aktiengesellschaft Method and System for Image-Based Estimation of Multi-Physics Parameters and Their Uncertainty for Patient-Specific Simulation of Organ Function
US20150290472A1 (en) * 2012-12-28 2015-10-15 Cyberheart, Inc. Blood-tissue surface based radiosurgical renal treatment planning
US20160157802A1 (en) * 2014-12-08 2016-06-09 Volcano Corporation Devices, systems, and methods for vessel assessment and intervention recommendation
WO2016168474A1 (en) * 2015-04-17 2016-10-20 Heartflow, Inc. Systems and methods for assessment of tissue function based on vascular disease
US20170178320A1 (en) * 2015-12-21 2017-06-22 Koninklijke Philips N.V. Device, system and method for quality assessment of medical images
US9754082B2 (en) 2014-05-30 2017-09-05 Heartflow, Inc. Systems and methods for reporting blood flow characteristics
US9953272B2 (en) 2013-10-23 2018-04-24 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US20190038239A1 (en) * 2017-08-03 2019-02-07 Siemens Healthcare Gmbh Ascertaining a function parameter relating to a local tissue function for plurality of tissue regions
US20190051022A1 (en) * 2016-03-03 2019-02-14 Sony Corporation Medical image processing device, system, method, and program
EP3503022A1 (en) * 2017-12-20 2019-06-26 Koninklijke Philips N.V. System for assessing a pulmonary image
US20190311526A1 (en) * 2016-12-28 2019-10-10 Panasonic Intellectual Property Corporation Of America Three-dimensional model distribution method, three-dimensional model receiving method, three-dimensional model distribution device, and three-dimensional model receiving device
US10497476B2 (en) 2013-05-10 2019-12-03 Stenomics, Inc. Modeling and simulation system for optimizing prosthetic heart valve treatment
US10674986B2 (en) 2016-05-13 2020-06-09 General Electric Company Methods for personalizing blood flow models
US20200411189A1 (en) * 2018-03-08 2020-12-31 Koninklijke Philips N.V. Resolving and steering decision foci in machine learning-based vascular imaging
US20210169455A1 (en) * 2019-12-04 2021-06-10 GE Precision Healthcare LLC System and methods for joint scan parameter selection
US11042822B2 (en) * 2014-04-01 2021-06-22 Heartflow, Inc. Systems and methods for using geometry sensitivity information for guiding workflow
US11071501B2 (en) 2015-08-14 2021-07-27 Elucid Bioiwaging Inc. Quantitative imaging for determining time to adverse event (TTE)
US11087459B2 (en) 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Quantitative imaging for fractional flow reserve (FFR)
US11087460B2 (en) 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Methods and systems for training and validating quantitative imaging biomarkers
US11107570B2 (en) * 2016-05-20 2021-08-31 Bayer Healthcare Llc Flexible, extensible and automated systems and methods for scoring the quality of radiology examinations
US11113812B2 (en) 2015-08-14 2021-09-07 Elucid Bioimaging Inc. Quantitative imaging for detecting vulnerable plaque
US11120312B2 (en) 2015-08-14 2021-09-14 Elucid Bioimaging Inc. Quantitative imaging for cancer subtype
US11419569B2 (en) * 2017-08-16 2022-08-23 Hologic, Inc. Image quality compliance tool
US11497451B2 (en) 2018-06-25 2022-11-15 Caption Health, Inc. Video clip selector for medical imaging and diagnosis
US11508063B2 (en) 2019-08-05 2022-11-22 Elucid Bioimaging Inc. Non-invasive measurement of fibrous cap thickness
US11523744B2 (en) 2017-03-31 2022-12-13 Koninklijke Philips N.V. Interaction monitoring of non-invasive imaging based FFR
US11615894B2 (en) 2012-10-24 2023-03-28 CathWorks, LTD. Diagnostically useful results in real time
US11617548B2 (en) 2004-11-26 2023-04-04 Hologic, Inc. Integrated multi-mode mammography/tomosynthesis x-ray system and method
US11666236B2 (en) 2016-05-16 2023-06-06 Cathworks Ltd. System for vascular assessment
US11676359B2 (en) 2015-08-14 2023-06-13 Elucid Bioimaging Inc. Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology
US20230187039A1 (en) * 2021-12-10 2023-06-15 International Business Machines Corporation Automated report generation using artificial intelligence algorithms
US11707196B2 (en) 2012-10-24 2023-07-25 Cathworks Ltd. Automated measurement system and method for coronary artery disease scoring
US11786191B2 (en) 2021-05-17 2023-10-17 Hologic, Inc. Contrast-enhanced tomosynthesis with a copper filter
US11813104B2 (en) 2017-10-06 2023-11-14 Emory University Methods and systems for determining hemodynamic information for one or more arterial segments
US11816837B2 (en) 2013-10-24 2023-11-14 Cathworks Ltd. Vascular characteristic determination with correspondence modeling of a vascular tree
US11871995B2 (en) 2017-12-18 2024-01-16 Hemolens Diagnostics Sp. Z O.O. Patient-specific modeling of hemodynamic parameters in coronary arteries
US11937963B2 (en) 2016-05-16 2024-03-26 Cathworks Ltd. Vascular selection from images
US12008751B2 (en) 2015-08-14 2024-06-11 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively
US12026868B2 (en) 2021-05-07 2024-07-02 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque erosion non-invasively

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105517492B (zh) * 2013-09-06 2019-10-18 皇家飞利浦有限公司 用于处理心脏数据的处理设备
US10354349B2 (en) 2014-04-01 2019-07-16 Heartflow, Inc. Systems and methods for using geometry sensitivity information for guiding workflow
JP6411073B2 (ja) * 2014-06-02 2018-10-24 キヤノンメディカルシステムズ株式会社 医用画像処理装置および医用画像処理方法
EP3192053B1 (en) * 2014-09-11 2021-03-31 Koninklijke Philips N.V. Quality metric for multi-beat echocardiographic acquisitions for immediate user feedback
US10080872B2 (en) 2014-11-04 2018-09-25 Abbott Cardiovascular Systems Inc. System and method for FFR guidewire recovery
US11141179B2 (en) * 2014-12-11 2021-10-12 Koninklijke Philips N.V. Setting of sonothromobolysis ultrasound output power
DE102014226685A1 (de) 2014-12-19 2016-06-23 Siemens Healthcare Gmbh Verfahren zum Identifizieren von Versorgungsgebieten,Verfahren zur graphischen Darstellung von Versorgungsgebieten, Computerprogramm und maschinenlesbares Medium sowie bildgebendes Gerät
KR20160107528A (ko) * 2015-03-04 2016-09-19 삼성전자주식회사 컴퓨터 보조 진단을 위한 신뢰도 제공 장치 및 방법
WO2016159379A1 (ja) * 2015-04-02 2016-10-06 イービーエム株式会社 血管形状構築装置、その方法及びコンピュータソフトウエアプログラム
KR102486700B1 (ko) * 2015-08-11 2023-01-11 삼성전자주식회사 혈압 추정 방법 및 장치
US10492754B2 (en) * 2015-11-20 2019-12-03 International Business Machines Corporation Real-time cloud-based virtual fractional flow reserve estimation
WO2017129564A1 (en) * 2016-01-27 2017-08-03 Koninklijke Philips N.V. Predictive model for optimizing clinical workflow
CN108701493A (zh) * 2016-02-29 2018-10-23 皇家飞利浦有限公司 用于验证医学图像的图像相关信息的设备、系统和方法
TWI589267B (zh) * 2016-03-10 2017-07-01 蘇志民 生物之系統及器官功能的微型化檢查裝置
TWI590183B (zh) * 2016-03-10 2017-07-01 蘇志民 生物之系統及器官功能的檢查系統及方法
CN105869218B (zh) * 2016-03-28 2018-08-14 中国科学院深圳先进技术研究院 血管数字模型的肿瘤病变编辑方法及装置
WO2017181288A1 (en) 2016-04-21 2017-10-26 The University Of British Columbia Echocardiographic image analysis
EP3485408A1 (en) * 2016-07-15 2019-05-22 Koninklijke Philips N.V. Apparatus for assessing medical device quality
US10839299B2 (en) * 2016-10-28 2020-11-17 International Business Machines Corporation Non-leading computer aided detection of features of interest in imagery
US10163209B2 (en) 2016-11-23 2018-12-25 Toshiba Medical Systems Corporation Medical image processing apparatus, medical image processing method, and X-ray CT apparatus
WO2018109114A1 (en) 2016-12-15 2018-06-21 Koninklijke Philips N.V. Prenatal ultrasound imaging
JP7313284B2 (ja) * 2017-04-06 2023-07-24 コーニンクレッカ フィリップス エヌ ヴェ 冠血流予備量比シミュレーションパラメータのカスタマイズ、キャリブレーション、及び／又はトレーニング
CN107296627B (zh) * 2017-07-14 2020-05-26 深圳市德力凯医疗设备股份有限公司 脑血流自动调节指数的输出方法、存储介质及超声设备
EP3659150B1 (en) * 2017-07-25 2024-03-06 Koninklijke Philips N.V. Device, system, and method for optimizing image acquisition workflows
GB2565306A (en) * 2017-08-08 2019-02-13 Vision Rt Ltd Method and apparatus for measuring the accuracy of models generated by a patient monitoring system
WO2019046003A1 (en) 2017-08-30 2019-03-07 Verily Life Sciences Llc GRANULARITY CONTRAST ANALYSIS USING AUTOMATIC LEARNING TO VISUALIZE A FLOW
EP3471054B1 (en) * 2017-10-16 2022-02-09 Siemens Healthcare GmbH Method for determining at least one object feature of an object
CN109965892A (zh) * 2017-12-27 2019-07-05 通用电气公司 冠状动脉ct成像方法及计算机可读存储介质
WO2019170493A1 (en) * 2018-03-08 2019-09-12 Koninklijke Philips N.V. Interactive self-improving annotation system for high-risk plaque burden assessment
US20210012887A1 (en) * 2018-03-15 2021-01-14 Koninklijke Philips N.V. Method of estimation physiological parameters using medical image data
EP3549529A1 (en) * 2018-04-05 2019-10-09 Koninklijke Philips N.V. Ultrasound imaging system and method
EP3564963A1 (en) * 2018-05-02 2019-11-06 Siemens Healthcare GmbH System and methods for fast computation of computed tomography based fractional flow reserve
US11389130B2 (en) 2018-05-02 2022-07-19 Siemens Healthcare Gmbh System and methods for fast computation of computed tomography based fractional flow reserve
US10751029B2 (en) 2018-08-31 2020-08-25 The University Of British Columbia Ultrasonic image analysis
JP6879277B2 (ja) * 2018-09-03 2021-06-02 コニカミノルタ株式会社 画像表示装置、放射線撮影システム、画像表示プログラム及び画像表示方法
CN109215764B (zh) * 2018-09-21 2021-05-04 苏州瑞派宁科技有限公司 一种医学图像四维可视化的方法及装置
CN109363661B (zh) * 2018-09-25 2022-02-01 杭州晟视科技有限公司 血流储备分数确定系统、方法、终端及存储介质
JP7059391B2 (ja) * 2018-10-09 2022-04-25 富士フイルム株式会社 流体解析装置、方法およびプログラム
US10803585B2 (en) 2018-10-09 2020-10-13 General Electric Company System and method for assessing image quality
US10937205B2 (en) * 2018-11-06 2021-03-02 Siemens Healthcare Gmbh Detection of infarcts using trained network
KR102236826B1 (ko) * 2018-11-30 2021-04-06 아주대학교산학협력단 기계학습용 의료 영상 데이터셋의 품질을 평가하는 방법 및 시스템
US10813612B2 (en) 2019-01-25 2020-10-27 Cleerly, Inc. Systems and method of characterizing high risk plaques
CN109949250B (zh) * 2019-03-29 2021-05-18 北京奇艺世纪科技有限公司 一种图像处理方法及装置
ES2938687T3 (es) * 2019-04-03 2023-04-13 Mecwins S A Procedimiento de detección óptica de biomarcadores
CN110084800B (zh) * 2019-04-28 2021-03-16 上海海事大学 一种用于四肢软组织肉瘤病人的肺转移预测方法
JP2022533401A (ja) * 2019-05-24 2022-07-22 コーニンクレッカ フィリップス エヌ ヴェ 連続モニタリングのために繰り返し超音波検査をガイドするためのデバイス、システム、及び方法
CN110428412B (zh) * 2019-07-31 2022-06-03 北京奇艺世纪科技有限公司 图像质量的评价及模型生成方法、装置、设备和存储介质
CN111513754A (zh) * 2019-09-16 2020-08-11 深圳迈瑞生物医疗电子股份有限公司 一种超声成像设备、超声图像的质量评估方法
US11367179B2 (en) * 2019-09-30 2022-06-21 GE Precision Healthcare LLC Determining degree of motion using machine learning to improve medical image quality
JP7350595B2 (ja) * 2019-10-01 2023-09-26 キヤノンメディカルシステムズ株式会社 画像処理装置、医用画像診断装置及び画像処理プログラム
CN111028180B (zh) * 2019-12-23 2021-11-09 腾讯科技（深圳）有限公司 图像处理方法、视频处理方法以及对应的装置
US20220392065A1 (en) 2020-01-07 2022-12-08 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
US11969280B2 (en) 2020-01-07 2024-04-30 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
JP2023509514A (ja) 2020-01-07 2023-03-08 クリールリー、 インコーポレーテッド 医用画像分析、診断、重症度分類、意思決定、および／または疾患追跡のためのシステム、方法、およびデバイス
WO2021213519A1 (zh) * 2020-04-23 2021-10-28 上海联影医疗科技股份有限公司 图像获取、判断图像质量、医学图像采集的方法和系统
EP3910644A1 (en) * 2020-05-12 2021-11-17 Koninklijke Philips N.V. Quality control in medical imaging
US11487651B2 (en) 2020-07-06 2022-11-01 Fujifilm Medical Systems U.S.A., Inc. Systems and methods for quantifying the effectiveness of software at displaying a digital record
US20220215956A1 (en) * 2021-01-05 2022-07-07 Shenzhen Keya Medical Technology Corporation System and method for image analysis using sequential machine learning models with uncertainty estimation
US11744535B2 (en) 2021-03-23 2023-09-05 International Business Machines Corporation Automated population based assessment of contrast absorption phases
WO2023097312A1 (en) * 2021-11-29 2023-06-01 Heartflow, Inc. Systems and methods for processing electronic images using user inputs
WO2023132846A1 (en) * 2022-01-06 2023-07-13 Rowan University Training a neural network for a predictive aortic aneurysm detection system
EP4209994A1 (en) 2022-01-10 2023-07-12 Median Technologies Method and system for automatic classification of radiographic images having different acquisition characteristics
US20230289963A1 (en) 2022-03-10 2023-09-14 Cleerly, Inc. Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination
EP4332982A1 (de) * 2022-08-29 2024-03-06 Siemens Healthineers AG Steuereinrichtung und verfahren zur steuerung eines medizintechnischen bildgebenden systems
KR102580749B1 (ko) * 2022-10-05 2023-09-19 서울대학교산학협력단 의료영상의 화질평가 방법 및 장치
CN117687554B (zh) * 2023-12-11 2024-05-28 上海梅斯医药科技有限公司 基于视觉模拟评分的标尺元件灵活配置系统及方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6633686B1 (en) * 1998-11-05 2003-10-14 Washington University Method and apparatus for image registration using large deformation diffeomorphisms on a sphere
US6909794B2 (en) * 2000-11-22 2005-06-21 R2 Technology, Inc. Automated registration of 3-D medical scans of similar anatomical structures
US20080123927A1 (en) * 2006-11-16 2008-05-29 Vanderbilt University Apparatus and methods of compensating for organ deformation, registration of internal structures to images, and applications of same
US20100069759A1 (en) * 2008-07-28 2010-03-18 Thomas Schuhrke Method for the quantitative display of blood flow
US20100086189A1 (en) * 2008-10-07 2010-04-08 Xiaohui Wang Automated quantification of digital radiographic image quality
US20120230565A1 (en) * 2007-03-08 2012-09-13 Sync-Rx, Ltd. Automatic quantitative vessel analysis

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5861731A (ja) * 1981-10-06 1983-04-12 株式会社東芝 コンピユ−タ・トモグラフイ装置
JPS5861731U (ja) 1981-10-20 1983-04-26 木原　裕 容器の蓋落下防止装置
US5872859A (en) * 1995-11-02 1999-02-16 University Of Pittsburgh Training/optimization of computer aided detection schemes based on measures of overall image quality
JP3502513B2 (ja) * 1996-09-25 2004-03-02 株式会社東芝 超音波画像処理方法および超音波画像処理装置
JP2004105437A (ja) * 2002-09-18 2004-04-08 Fuji Photo Film Co Ltd 医用画像処理装置及び医用画像撮影システム
JP2005028114A (ja) * 2003-06-18 2005-02-03 Canon Inc 放射線撮影装置及び放射線撮影方法
DE602006013864D1 (de) * 2005-09-15 2010-06-02 Hitachi Medical Corp Röntgen-ct-gerät
US8140997B2 (en) 2005-12-26 2012-03-20 International Business Machines Corporation Manipulating display of multiple display objects
JP2007260292A (ja) * 2006-03-29 2007-10-11 Toshiba Corp 画像処理装置及びプログラム
US7940970B2 (en) * 2006-10-25 2011-05-10 Rcadia Medical Imaging, Ltd Method and system for automatic quality control used in computerized analysis of CT angiography
US8023714B2 (en) * 2007-06-06 2011-09-20 Aperio Technologies, Inc. System and method for assessing image interpretability in anatomic pathology
EP2037282A3 (en) * 2007-06-15 2012-09-12 Ortho-Clinical Diagnostics, Inc. Clinical diagnostic analyzer performance estimator
US20090138318A1 (en) * 2007-11-20 2009-05-28 General Electric Company Systems and methods for adaptive workflow and resource prioritization
WO2009106784A1 (en) * 2008-02-25 2009-09-03 Inventive Medical Limited Medical training method and apparatus
CN101320526B (zh) * 2008-07-11 2010-12-22 深圳先进技术研究院 一种手术预测和训练的设备及其方法
WO2010046802A1 (en) * 2008-10-20 2010-04-29 Koninklijke Philips Electronics, N.V. Image-based localization method and system
JP5400588B2 (ja) * 2008-12-11 2014-01-29 富士フイルム株式会社 放射線画像撮影システム
JP5514450B2 (ja) * 2009-02-23 2014-06-04 株式会社日立メディコ Ｘ線ｃｔ装置
US20110235885A1 (en) * 2009-08-31 2011-09-29 Siemens Medical Solutions Usa, Inc. System for Providing Digital Subtraction Angiography (DSA) Medical Images
US8520920B2 (en) * 2009-11-11 2013-08-27 Siemens Corporation System for dynamically improving medical image acquisition quality
JP5677757B2 (ja) * 2010-03-16 2015-02-25 ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー 超音波診断装置
US8645165B2 (en) * 2010-06-03 2014-02-04 General Electric Company Systems and methods for value-based decision support
JP5868052B2 (ja) * 2010-07-21 2016-02-24 シーメンス アクチエンゲゼルシヤフトＳｉｅｍｅｎｓ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 包括的な患者固有の心臓のモデリング方法およびシステム
US8682626B2 (en) * 2010-07-21 2014-03-25 Siemens Aktiengesellschaft Method and system for comprehensive patient-specific modeling of the heart
US8157742B2 (en) 2010-08-12 2012-04-17 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
US8315812B2 (en) 2010-08-12 2012-11-20 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
JP5642476B2 (ja) * 2010-09-28 2014-12-17 ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー 画像処理装置およびプログラム並びにｘ線ｃｔ装置
JP5697422B2 (ja) * 2010-12-10 2015-04-08 株式会社日立メディコ Ｘ線診断装置
JP5550586B2 (ja) * 2011-03-01 2014-07-16 株式会社東芝 医用画像診断装置と超音波診断装置と画像処理方法
WO2013062049A1 (ja) * 2011-10-25 2013-05-02 株式会社 東芝 Ｘ線コンピュータ断層撮影装置
US9262581B2 (en) 2012-09-24 2016-02-16 Heartflow, Inc. Method and system for facilitating physiological computations
US9890928B2 (en) 2012-12-05 2018-02-13 Philips Lighting Holding B.V. Flat lighting device
US9424395B2 (en) 2013-03-04 2016-08-23 Heartflow, Inc. Method and system for sensitivity analysis in modeling blood flow characteristics
KR20150061055A (ko) * 2013-11-25 2015-06-04 삼성전자주식회사 관상동맥 cta 영상으로부터 관상동맥의 병변을 검출하는 방법 및 장치
JP5861731B2 (ja) 2014-03-27 2016-02-16 カシオ計算機株式会社 携帯端末
US10074038B2 (en) * 2016-11-23 2018-09-11 General Electric Company Deep learning medical systems and methods for image reconstruction and quality evaluation
DE102017221297A1 (de) * 2017-11-28 2019-05-29 Siemens Healthcare Gmbh Verfahren und Vorrichtung zur automatisierten Auswertung wenigstens eines mit einer medizinischen Bildaufnahmeeinrichtung aufgenommenen Bilddatensatzes, Computerprogramm und elektronisch lesbarer Datenträger

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6633686B1 (en) * 1998-11-05 2003-10-14 Washington University Method and apparatus for image registration using large deformation diffeomorphisms on a sphere
US6909794B2 (en) * 2000-11-22 2005-06-21 R2 Technology, Inc. Automated registration of 3-D medical scans of similar anatomical structures
US20080123927A1 (en) * 2006-11-16 2008-05-29 Vanderbilt University Apparatus and methods of compensating for organ deformation, registration of internal structures to images, and applications of same
US20120230565A1 (en) * 2007-03-08 2012-09-13 Sync-Rx, Ltd. Automatic quantitative vessel analysis
US20100069759A1 (en) * 2008-07-28 2010-03-18 Thomas Schuhrke Method for the quantitative display of blood flow
US20100086189A1 (en) * 2008-10-07 2010-04-08 Xiaohui Wang Automated quantification of digital radiographic image quality

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cemil Kirbas et al., "A Review of Vessel Extraction Techniques and Algorithms", ACM Computing Surveys, vol. 36, No. 2, Jun. 2004, pp. 81-121.

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11617548B2 (en) 2004-11-26 2023-04-04 Hologic, Inc. Integrated multi-mode mammography/tomosynthesis x-ray system and method
US11615894B2 (en) 2012-10-24 2023-03-28 CathWorks, LTD. Diagnostically useful results in real time
US11707196B2 (en) 2012-10-24 2023-07-25 Cathworks Ltd. Automated measurement system and method for coronary artery disease scoring
US11728037B2 (en) 2012-10-24 2023-08-15 Cathworks Ltd. Diagnostically useful results in real time
US11844959B2 (en) 2012-12-28 2023-12-19 Varian Medical Systems, Inc. Blood-tissue surface based radiosurgical renal treatment planning
US11154725B2 (en) 2012-12-28 2021-10-26 Varian Medical Systems, Inc. Blood-tissue surface based radiosurgical renal treatment planning
US20150290472A1 (en) * 2012-12-28 2015-10-15 Cyberheart, Inc. Blood-tissue surface based radiosurgical renal treatment planning
US20140324400A1 (en) * 2013-04-30 2014-10-30 Marquette University Gesture-Based Visualization System for Biomedical Imaging and Scientific Datasets
US11315690B2 (en) 2013-05-10 2022-04-26 Stenomics, Inc. Modeling and simulation system for optimizing prosthetic heart valve treatment
US10497476B2 (en) 2013-05-10 2019-12-03 Stenomics, Inc. Modeling and simulation system for optimizing prosthetic heart valve treatment
US20150025330A1 (en) * 2013-07-19 2015-01-22 Volcano Corporation Devices, Systems, and Methods for Assessment of Vessels
US10226189B2 (en) * 2013-07-19 2019-03-12 Volcano Corporation Devices, systems, and methods for assessment of vessels
US11298030B2 (en) * 2013-07-19 2022-04-12 Philips Image Guided Therapy Corporation Devices systems and methods for assessment of vessels
US11857296B2 (en) * 2013-07-19 2024-01-02 Philips Image Guided Therapy Corporation Devices, systems, and methods for assessment of vessels
US20220225884A1 (en) * 2013-07-19 2022-07-21 Philips Image Guided Therapy Corporation Devices, systems, and methods for assessment of vessels
US10762442B2 (en) 2013-10-23 2020-09-01 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US9953272B2 (en) 2013-10-23 2018-04-24 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US11024425B2 (en) 2013-10-23 2021-06-01 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US11024426B2 (en) 2013-10-23 2021-06-01 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US10943698B2 (en) 2013-10-23 2021-03-09 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US11816837B2 (en) 2013-10-24 2023-11-14 Cathworks Ltd. Vascular characteristic determination with correspondence modeling of a vascular tree
US20150242589A1 (en) * 2014-02-25 2015-08-27 Siemens Aktiengesellschaft Method and System for Image-Based Estimation of Multi-Physics Parameters and Their Uncertainty for Patient-Specific Simulation of Organ Function
US10496729B2 (en) * 2014-02-25 2019-12-03 Siemens Healthcare Gmbh Method and system for image-based estimation of multi-physics parameters and their uncertainty for patient-specific simulation of organ function
US11042822B2 (en) * 2014-04-01 2021-06-22 Heartflow, Inc. Systems and methods for using geometry sensitivity information for guiding workflow
US10878963B2 (en) 2014-05-30 2020-12-29 Heartflow, Inc. Systems and methods for reporting blood flow characteristics
US9754082B2 (en) 2014-05-30 2017-09-05 Heartflow, Inc. Systems and methods for reporting blood flow characteristics
US10169543B2 (en) 2014-05-30 2019-01-01 Heartflow, Inc. Systems and methods for reporting blood flow characteristics
US11309071B2 (en) * 2014-12-08 2022-04-19 Philips Image Guided Therapy Corporation Devices, systems, and methods for vessel assessment and intervention recommendation
US20160157802A1 (en) * 2014-12-08 2016-06-09 Volcano Corporation Devices, systems, and methods for vessel assessment and intervention recommendation
US11605466B2 (en) 2015-04-17 2023-03-14 Heartflow, Inc. Systems and methods for assessment of tissue function based on vascular disease
US10007762B2 (en) 2015-04-17 2018-06-26 Heartflow, Inc. Systems and methods for assessment of tissue function based on vascular disease
WO2016168474A1 (en) * 2015-04-17 2016-10-20 Heartflow, Inc. Systems and methods for assessment of tissue function based on vascular disease
US11120312B2 (en) 2015-08-14 2021-09-14 Elucid Bioimaging Inc. Quantitative imaging for cancer subtype
US11087460B2 (en) 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Methods and systems for training and validating quantitative imaging biomarkers
US11094058B2 (en) 2015-08-14 2021-08-17 Elucid Bioimaging Inc. Systems and method for computer-aided phenotyping (CAP) using radiologic images
US11607179B2 (en) 2015-08-14 2023-03-21 Elucid Bioimaging Inc. Non-invasive risk stratification for atherosclerosis
US11113812B2 (en) 2015-08-14 2021-09-07 Elucid Bioimaging Inc. Quantitative imaging for detecting vulnerable plaque
US11087459B2 (en) 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Quantitative imaging for fractional flow reserve (FFR)
US11071501B2 (en) 2015-08-14 2021-07-27 Elucid Bioiwaging Inc. Quantitative imaging for determining time to adverse event (TTE)
US11676359B2 (en) 2015-08-14 2023-06-13 Elucid Bioimaging Inc. Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology
US12008751B2 (en) 2015-08-14 2024-06-11 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively
US11696735B2 (en) 2015-08-14 2023-07-11 Elucid Bioimaging Inc. Quantitative imaging for instantaneous wave-free ratio
US10402967B2 (en) * 2015-12-21 2019-09-03 Koninklijke Philips N.V. Device, system and method for quality assessment of medical images
US20170178320A1 (en) * 2015-12-21 2017-06-22 Koninklijke Philips N.V. Device, system and method for quality assessment of medical images
US20190051022A1 (en) * 2016-03-03 2019-02-14 Sony Corporation Medical image processing device, system, method, and program
US11244478B2 (en) * 2016-03-03 2022-02-08 Sony Corporation Medical image processing device, system, method, and program
US10674986B2 (en) 2016-05-13 2020-06-09 General Electric Company Methods for personalizing blood flow models
US11937963B2 (en) 2016-05-16 2024-03-26 Cathworks Ltd. Vascular selection from images
US11666236B2 (en) 2016-05-16 2023-06-06 Cathworks Ltd. System for vascular assessment
US11600377B2 (en) 2016-05-20 2023-03-07 Bayer Healthcare Llc Flexible, extensible and automated systems and methods for scoring the quality of radiology examinations
US11107570B2 (en) * 2016-05-20 2021-08-31 Bayer Healthcare Llc Flexible, extensible and automated systems and methods for scoring the quality of radiology examinations
US11551408B2 (en) * 2016-12-28 2023-01-10 Panasonic Intellectual Property Corporation Of America Three-dimensional model distribution method, three-dimensional model receiving method, three-dimensional model distribution device, and three-dimensional model receiving device
US20190311526A1 (en) * 2016-12-28 2019-10-10 Panasonic Intellectual Property Corporation Of America Three-dimensional model distribution method, three-dimensional model receiving method, three-dimensional model distribution device, and three-dimensional model receiving device
US11523744B2 (en) 2017-03-31 2022-12-13 Koninklijke Philips N.V. Interaction monitoring of non-invasive imaging based FFR
US20190038239A1 (en) * 2017-08-03 2019-02-07 Siemens Healthcare Gmbh Ascertaining a function parameter relating to a local tissue function for plurality of tissue regions
US10959685B2 (en) * 2017-08-03 2021-03-30 Siemens Healthcare Gmbh Ascertaining a function parameter relating to a local tissue function for plurality of tissue regions
US11419569B2 (en) * 2017-08-16 2022-08-23 Hologic, Inc. Image quality compliance tool
US11672500B2 (en) 2017-08-16 2023-06-13 Hologic, Inc. Image quality compliance tool
US12011310B2 (en) * 2017-08-16 2024-06-18 Hologic, Inc. Image quality compliance tool
US11813104B2 (en) 2017-10-06 2023-11-14 Emory University Methods and systems for determining hemodynamic information for one or more arterial segments
US11871995B2 (en) 2017-12-18 2024-01-16 Hemolens Diagnostics Sp. Z O.O. Patient-specific modeling of hemodynamic parameters in coronary arteries
CN111630562A (zh) * 2017-12-20 2020-09-04 皇家飞利浦有限公司 用于评估肺部图像的系统
EP3503022A1 (en) * 2017-12-20 2019-06-26 Koninklijke Philips N.V. System for assessing a pulmonary image
WO2019121369A1 (en) * 2017-12-20 2019-06-27 Koninklijke Philips N.V. System and method for assessing a pulmonary image
US11657500B2 (en) 2017-12-20 2023-05-23 Koninklijke Philips N.V. System and method for assessing a pulmonary image
US11721439B2 (en) * 2018-03-08 2023-08-08 Koninklijke Philips N.V. Resolving and steering decision foci in machine learning-based vascular imaging
US20200411189A1 (en) * 2018-03-08 2020-12-31 Koninklijke Philips N.V. Resolving and steering decision foci in machine learning-based vascular imaging
US11497451B2 (en) 2018-06-25 2022-11-15 Caption Health, Inc. Video clip selector for medical imaging and diagnosis
US11508063B2 (en) 2019-08-05 2022-11-22 Elucid Bioimaging Inc. Non-invasive measurement of fibrous cap thickness
US20210169455A1 (en) * 2019-12-04 2021-06-10 GE Precision Healthcare LLC System and methods for joint scan parameter selection
US12026868B2 (en) 2021-05-07 2024-07-02 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque erosion non-invasively
US11786191B2 (en) 2021-05-17 2023-10-17 Hologic, Inc. Contrast-enhanced tomosynthesis with a copper filter
US20230187039A1 (en) * 2021-12-10 2023-06-15 International Business Machines Corporation Automated report generation using artificial intelligence algorithms
US12014807B2 (en) * 2021-12-10 2024-06-18 Merative Us L.P. Automated report generation using artificial intelligence algorithms

Also Published As

Publication number Publication date
JP2017170262A (ja) 2017-09-28
US9836840B2 (en) 2017-12-05
EP2803038B1 (en) 2020-01-15
US11494904B2 (en) 2022-11-08
EP2803038A1 (en) 2014-11-19
US20200311936A1 (en) 2020-10-01
WO2014149496A1 (en) 2014-09-25
JP2020080165A (ja) 2020-05-28
AU2016222402B2 (en) 2018-07-05
US10719931B2 (en) 2020-07-21
US20240013388A1 (en) 2024-01-11
DE202014010689U1 (de) 2016-04-27
JP2019048060A (ja) 2019-03-28
US9008405B2 (en) 2015-04-14
KR102172182B1 (ko) 2020-10-30
US20140270427A1 (en) 2014-09-18
US20140275946A1 (en) 2014-09-18
JP6255473B2 (ja) 2017-12-27
JP6410891B2 (ja) 2018-10-24
US20140275947A1 (en) 2014-09-18
US20160300349A1 (en) 2016-10-13
US20150086093A1 (en) 2015-03-26
JP6656331B2 (ja) 2020-03-04
DE202014010690U1 (de) 2016-04-27
EP3664026A1 (en) 2020-06-10
US8831314B1 (en) 2014-09-09
CN105051784B (zh) 2017-05-17
KR20150132191A (ko) 2015-11-25
KR20200124767A (ko) 2020-11-03
KR102312011B1 (ko) 2021-10-14
US20180068445A1 (en) 2018-03-08
US20220277446A1 (en) 2022-09-01
AU2014238124A1 (en) 2015-09-10
US20140376797A1 (en) 2014-12-25
US8861820B2 (en) 2014-10-14
CA2904832A1 (en) 2014-09-25
AU2016222402A1 (en) 2016-09-15
US11803965B2 (en) 2023-10-31
US8831315B1 (en) 2014-09-09
CA2904832C (en) 2017-04-25
CN105051784A (zh) 2015-11-11
US20140275945A1 (en) 2014-09-18
EP3664026B1 (en) 2022-02-09
US9672615B2 (en) 2017-06-06
JP2016513530A (ja) 2016-05-16

Similar Documents

Publication Publication Date Title
US11494904B2 (en) Methods and systems for assessing image quality in modeling of patient anatomic or blood flow characteristics
US20230148977A1 (en) Systems and methods for numerically evaluating vasculature

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

AS Assignment

Owner name: HEARTFLOW, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FONTE, TIMOTHY A.;GRADY, LEO J.;WU, ZHONGLE;AND OTHERS;SIGNING DATES FROM 20140115 TO 20140116;REEL/FRAME:032353/0046

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551)

Year of fee payment: 4

AS Assignment

Owner name: HAYFIN SERVICES LLP, UNITED KINGDOM

Free format text: SECURITY INTEREST;ASSIGNOR:HEARTFLOW, INC.;REEL/FRAME:055037/0890

Effective date: 20210119

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 8